Capecitabine: 133 Real Stories

133 stories match capecitabine. 107 of them mention surgery.

Cancer Stories

A patient, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer Treatment Complicated by Scleroderma-Like Skin Changes

Patient Info: Anonymized, female, 50s | Stage II

Biomarkers: ER low-positive; PR-negative; HER2-negative

Her cancer remained stable during combination treatment. After morphea-like skin changes developed during therapy, treatment was modified and the skin condition improved 6 months after docetaxel was stopped.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Colon cancer that later spread to the testis and liver

Patient Info: Anonymized, male, 60s | Stage IV

Metastatic Site: right testis, liver

Liver metastasis was found 6 months after orchiectomy. Telephone follow-up confirmed that he survived for more than 18 months after the testicular surgery.

PubMed Central
OutcomeSetback / Progression
Jessica, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Jessica's Survivor Story

Patient Info: Jessica Dazzler, Female, Under 40 | Stage IV

Biomarkers: FoundationOne testing performed; exact mutation not stated

Metastatic Site: lungs, spine, rib

As of May 2024, Jessica said it took 3 years and 4 months to reach no evidence of disease after Stage IV colorectal cancer, though she remained anxious about future scans and possible circulating cancer.

The Patient Story
OutcomeCancer-Free / NED
Michael, who was diagnosed with Stage III Colorectal AdenocarcinomaColorectal Cancer

Stage III Colorectal Adenocarcinoma: Michael's Survivor Story

Patient Info: Michael Holtz, Male, 40s | Stage III

Michael reported that capecitabine with radiation, surgery, and FOLFOX worked for him; current surveillance findings and recurrence status were not provided.

Fight Colorectal Cancer
OutcomeSurvivorship / Completed Treatment
A patient, who was diagnosed with Invasive Ductal CarcinomaBreast Cancer

Freezing treatment (cryoablation) used to manage slow-growing triple-negative breast cancer

Patient Info: Anonymized, Female | Stage Metastatic/Advanced

Biomarkers: ER-negative; PR-negative; HER2-negative; androgen receptor-positive in original tumor; Ki-67 5% initially and 10% at recurrence

At 29 months after recurrence diagnosis and 20 months after the first cryoablation, no viable breast tumor was seen at treated sites, axillary nodes were unchanged, pain was absent, and she remained active and independent.

PubMed Central
OutcomeStable
Savannah, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

Stage II Colorectal Cancer: Savannah's Survivor Story

Patient Info: Savannah Kaspar, Female, Under 40 | Stage II

Biomarkers: Lynch syndrome genetic testing negative

As of March 2024, Savannah had completed partial colectomy and 4 rounds of adjuvant chemotherapy for Stage II sigmoid colon cancer and had entered surveillance with bloodwork every 3 months.

MD Anderson
OutcomeSurvivorship / Surveillance
Courtney, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

How I KNEW I Had COLON CANCER

Patient Info: Courtney, Female | Stage III

As of March 2024, Courtney was nearly 3 years in remission after surgery and adjuvant chemotherapy for Stage IIIA colorectal cancer, with follow-up every 6 months.

The Patient Story
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

Metastatic hormone receptor-positive breast cancer with paraneoplastic eosinophilic fasciitis

Patient Info: Anonymized, Female, 70+ | Stage IV

Biomarkers: ER-positive; PR-positive; eosinophilia during paraneoplastic eosinophilic fasciitis flare

Metastatic Site: pelvis

As of February 2024, paraneoplastic eosinophilic fasciitis had remitted after prednisone plus systemic breast-cancer therapy, and 6-month follow-up showed no further skin recurrence or cancer progression.

PubMed Central
OutcomeResponding Well
Jelena, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Jelena's Survivor Story

Patient Info: Jelena, Female, Under 40 | Stage III

As of January 2024, Jelena was on annual follow-up after Stage III rectal cancer treatment, with her latest colonoscopy showing no polyps or suspicious findings.

The Patient Story
OutcomeCancer-Free / NED
A patient, who was diagnosed with Colorectal Squamous Cell CarcinomaColorectal Cancer

Understanding rectal squamous cell carcinoma, a rare form of rectal cancer

Patient Info: Anonymized, Female

Biomarkers: SCC antigen 0.6 ng/mL at 6-month response assessment

A complete response was established at 6 months, and she remained without clinical, laboratory or imaging evidence of disease 2 years after treatment.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Rectal signet ring cell cancer with an unusual metastasis into a lipoma

Patient Info: Anonymized, male, 40s | Stage IV

Metastatic Site: subcutaneous abdominal wall lipoma, peritoneum

Peritoneal carcinomatosis developed during adjuvant FOLFOX. Second-line chemotherapy was proposed, and he died 12 months later.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Colorectal AdenocarcinomaColorectal Cancer

Colorectal cancer: using a blood test (ctDNA) to guide immunotherapy after surgery — Case 1

Patient Info: Anonymized, Male, 50s

Biomarkers: KRAS ; TMB 11 mutations/Mb; loss of MLH1 and PMS2; dMMR/MSI-H; germline multigene panel negative; ctDNA positive after surgery and chemotherapy

Pembrolizumab cleared ctDNA within about 3 months. After completing 1 year of immunotherapy, surveillance CT showed no evidence of disease and ctDNA remained negative.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Breast Cancer Recurs After a 19-Year Remission and Responds to Later Chemotherapy

Patient Info: Anonymized, female, 50s | Stage IV

Biomarkers: Initial tumor: PR-positive, ER-negative, HER2-negative. Recurrence: ER-positive, PR-negative

Metastatic Site: bones

The cancer recurred after a 19-year remission and later spread to bone. More than 21 years after the original diagnosis, she had marked tumor shrinkage, was in good general condition, and had 10 months of progression-free survival after utidelone plus capecitabine.

PubMed Central
OutcomeResponding Well
A patient, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Treatment-Refractory Triple-Negative Breast Cancer Treated With Tumor-Infiltrating Lymphocytes

Patient Info: Anonymized, female, Under 40 | Stage IV

Biomarkers: Germline BRCA1 pathogenic variant; later triple-negative phenotype

Metastatic Site: skin, lungs, bones

Tumor burden briefly decreased after tumor-infiltrating lymphocyte therapy, but she developed severe treatment complications followed by rapid cancer relapse and died about 1 month after the TIL/IL-2 treatment began.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Stage II Gastric CancerGastric Cancer

Gastric Cancer Treatment Interrupted by Capecitabine-Related Brain Toxicity

Patient Info: Anonymized, Female | Stage II

Her cognition and vital signs improved over several days after capecitabine was stopped. At follow-up 2 weeks later, chemotherapy remained suspended and the treatment plan was revised to radiation alone.

PubMed Central
OutcomeCare Ongoing
Stephanie, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Stephanie's Survivor Story

Patient Info: Stephanie, Female, Under 40 | Stage III

As of November 2023, Stephanie reported that her oncologist said her cancer was in remission after surgery and chemotherapy, with CT/lab follow-up and a PET scan for reassurance.

The Patient Story
OutcomeCancer-Free / NED
Kelly, who was diagnosed with Stage III Breast CancerBreast Cancer

Kelly's Stage 3 Breast Cancer Story: “I’m Still Here & THRIVING!"

Patient Info: Kelly Thomas, Female, Under 40 | Stage III

Biomarkers: Initial triple-negative breast cancer; after surgery

As of August 2023, Kelly was 5 years from her Stage IIIC triple-negative breast cancer diagnosis with no recurrence reported.

The Patient Story
OutcomeCancer-Free / NED